Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


17 Items
Title  Creator  Group name  Publishing year 
Comprehensive commissioning and quality assurance validation of Ethos? therapy Morel et al. EquipeJPP 2023-09
Acceptance, commissioning and quality assurance of the MRIdian®: Site experience and three years follow-up Valdenaire et al. EquipeJPP 2023-06
[Treatment of oligometastatic or oligoprogression cancer] Bourgier et al. EquipeAP Sep 05, 2019
[Predictive assays for responses of tumors and normal tissues in radiation oncology] Riou et al. EquipeAP Aug 23, 2019
[Liver stereotactic body radiotherapy: Clinical features and technical consequences, results. Which treatment machine in which situation?] Riou et al. EquipeMY Aug 20, 2019
[Individual modification of the dose, volume and fractionation of breast radiotherapy] Bourgier et al. EquipeJPP 2019-10
[The major debate: Micrometastases and breast cancer - To be for nodal irradiation] Bourgier et al. EquipeAP Aug 22, 2018
[Modalities and advantages of image guided radiation therapy of breast cancer in adjuvant setting] Kammerer et al. EquipeAP Aug 22, 2018
Prospective medical analysis of radiation therapist image repositioning during image-guided radiotherapy Lauche et al. EquipeNB Feb 2018
Imaged-guided liver stereotactic body radiotherapy using VMAT and real-time adaptive tumor gating. Concerns about technique and preliminary clinical results Llacer-Moscardo et al. EquipePM Mar-Apr 2017
[Radiotherapy of bladder cancer] Riou et al. EquipeNB Sep 2016
[Radiomics: Definition and clinical development] Bourgier et al. EquipeJC Oct 2015
[Impact of intensity-modulated radiotherapy on node irradiation for breast cancer] Fenoglietto et al. EquipeNB Jun 2015
[Does nodal irradiation (clavicular and internal mammary chains) increase the toxicity of adjuvant breast radiotherapy?] Riou et al. EquipeNB Jun 2015
Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial Azria et al. EquipeAP Dec 2015
Concurrent or sequential letrozole with adjuvant breast radiotherapy: Final results of the CO-HO-RT phase II randomized trial Bourgier et al. EquipeAP Dec 17, 2015
[Stereotactic body radiation therapy and oligometastases] Bourgier et al. EquipeNB 2014 Jul-Aug
17 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés